| ONCO-INNOVATIONS LTD. |
| Kanada |
| Gesundheit |
| CA68237C1059 / A3EKSZ |
| W1H (Frankfurt) |
| FRA:W1H, ETR:W1H, W1H:GR |
| - |
| https://oncoinnovations.c.. |
|
Onco-Innovations Limited is a pre-clinical stage biotechnology company focused on the development of innovative drug candidates targeting cancer. The company’s primary mission is to advance next-generation therapies that address unmet clinical need..
>Volltext.. |
| 54.73 Mio. EUR |
| 54.83 Mio. EUR |
| 0.06 Mio. EUR |
| -6.44 Mio. EUR |
| -7.09 Mio. EUR |
| -0.12 EUR |
| 0.17 Mio. EUR |
| 0.07 Mio. EUR |
| -2.52 Mio. EUR |
| 0.07 |
| 4.89% |
| -3.68% |
| - |
| - |
| - |
| - |
| ONCO-INNOVATIONS, ONCO INNOVATIONS |
| 17.09.26 |
|